-
NEW FAILURE MODES, OLD STANDARDS: WHY ARTIFICIAL INTELLIGENCE (AI) DEMANDS DIFFERENT VALIDATION APPROACHES IN EVIDENCE SYNTHESIS
Mar 18, 2026, 21:38 PM -
SOCIO-DEMOGRAPHIC FACTORS AND ADHERENCE TO COLORECTAL CANCER SCREENING GUIDELINES IN THE UNITED STATES: EVIDENCE FROM BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM DATA
Mar 18, 2026, 21:38 PM -
IMPROVING FINITE-SAMPLE EFFICIENCY IN CAUSAL INFERENCE: A REGULARIZED STABILIZED IPTW ESTIMATOR
Mar 18, 2026, 21:38 PM -
REAL-WORLD HEALTH DISPARITIES IN TIME TO NEXT TREATMENT FOLLOWING FIRST-LINE THERAPY FOR ADVANCED AND RECURRENT ENDOMETRIAL CANCER IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF CDK4/6 INHIBITORS FOR HR+/HER2- METASTATIC BREAST CANCER IN KAZAKHSTAN
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF CARDIOVASCULAR BENEFIT OF SEMAGLUTIDE VERSUS TIRZEPATIDE IN PATIENTS WITH OVERWEIGHT OR OBESITY IN CHINA
Mar 18, 2026, 21:38 PM -
COMPARATIVEEFFECTIVENESS OF ANTIBIOTICS PLUS SUHUANG ZHIKE CAPSULES VERSUS ANTIBIOTICS ALONE FOR COUGH USING REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
PRODUCTIVITY LOSSES AFTER MISCARRIAGE: A PROSPECTIVE COHORT ANALYSIS USING THE IMTA PRODUCTIVITY COST QUESTIONNAIRE
Mar 18, 2026, 21:38 PM -
RELATIONSHIP BETWEEN IMPROVEMENT IN LUNG FUNCTION AND SYMPTOMS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH DUPILUMAB
Mar 18, 2026, 21:38 PM -
COST-UTILITY MODEL OF MATERNAL RSV VACCINATION FROM THE PERSPECTIVE OF THE BRAZILIAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
DEVELOPING DIRECT EQUITY WEIGHTS FOR COST-EFFECTIVENESS ANALYSIS: RESULTS FROM A US-BASED DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
DESCRIBING THE ROLE OF CAREGIVERS IN ATTR-CM: A SECONDARY ANALYSIS OF SURVEY DATA FROM GERMANY AND SPAIN
Mar 18, 2026, 21:38 PM -
PERCEIVED CLINICAL VALUE AND COST TRADE-OFF IN PSYCHOLOGY A REAL-WORLD ANALYSIS BASED ON PROMS, PREMS, AND COSTS
Mar 18, 2026, 21:38 PM -
THERAPEUTIC ROLE OF ALISKIREN MONOTHERAPY IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF ANTIHYPERTENSIVE AND ANTIPROTEINURIC EFFECTS
Mar 18, 2026, 21:38 PM -
ASSESSING THE ABILITY OF THE EQ-5D-5L TO CAPTURE LONG-TERM HEALTH-RELATED QUALITY OF LIFE IMPACTS OF HEREDITARY ANGIOEDEMA ATTACKS
Mar 18, 2026, 21:38 PM -
UNDERSTANDING DISEASE COMPLEXITY IN GRAVES’ DISEASE: A POPULATION-BASED NETWORK ANALYSIS OF COMORBIDITIES
Mar 18, 2026, 21:38 PM -
A U.S.-SPECIFIC BUDGET IMPACT MODEL (BIM) OF SEMAGLUTIDE 2.4 MG IN THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) USING MOST FAVORED NATION (MFN) PRICING
Mar 18, 2026, 21:38 PM -
UNLOCKING THE SOCIOECONOMIC BENEFITS OF ADULT RESPIRATORY VACCINATION IN MEXICO: THE CASE FOR BROADER PREVENTION STRATEGIES
Mar 18, 2026, 21:38 PM -
HEALTHCARE COSTS AND CLINICAL OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED MASH OR SUSPECTED MASH WITH HIGH FIB-4 SCORE IN U.S. ADULTS
Mar 18, 2026, 21:38 PM -
LONG-TERM TRENDS IN PRESCRIPTION MEDICATION CLASS USE AMONG ADULTS IN THE UNITED STATES, 2010-2023
Mar 18, 2026, 21:38 PM
